Cell counting is a technique used for determining physical properties of cells such as concentration, density, and viability. Cell counting method is adopted by doctors also, so as to know the condition of the patient. They use this method for estimating the concentration of white blood cells, red blood cells, platelets, etc. and the amount of it tells the health status of patients. Cells counting can be done either manually through hemocytometer where in the volumetric grid of it is used for estimating the concentration of cells, or by plating the microbes into petri dish containing growth medium.
Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/2710
Key players are focused on developing new products for cell counting, which is expected to propel the global cell counting devices market growth. For instance, in January 2019, DeNovix Inc. launched a product, Cell Drop Automated Cell Counter for analysis of cell culture. It has dual fluorescence and bright-field optics, and also, easy to use analyzer. It includes direct pipette technology, which ensures precise and accurate cell suspension. It does not require any calibration. It is designed with the aim to eliminate the slides and the complex method of hemocytometer.
Moreover, key players also actively involved in participating in conferences and events related to cell counting device. For instance, in February 2019, BioRad Laboratories Inc. participated in Society for Laboratory Automation and Screening 2019 (SLAS), held in Washington D.C., wherein it showcased its product, ZE5 cell analyzer. It consists a robotic arm, which ensures precise and accurate measurements of additions of reagents and also enables easy integration of fluids. It is capable of processing 96 or 384 plates under 60 minutes.
In 2017, GE Healthcare, a company that designs imaging and monitoring systems entered into a partnership with Guangzhou RiboBio Co., Ltd., a biotechnology company to establish oligonucleotide drug development and manufacturing facility in China. GE healthcare provided all the advanced instruments, which also includes IN Cell Analyzer 6500H, while Guangzhou RiboBio supported the infrastructure and provided with the staff. IN Cell Analyzer 6500H is an imaging system based on IRIS confocal technology. Its features live cell imaging, three dimensional imaging, and higher throughput.
Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2710
Moreover, in April 2019, Nexcelom Bioscience, a manufacturer of cell counting and characterization products released Cellaca MX. It is an automated cell counter consisting of bright field and fluorescence imaging cytometry. Around 24 samples can be processed in 48 seconds allowing high throughput and high speed. Hence, these factors are expected to drive the global cell counting devices market growth.
Major players operating in the global cell counting devices market include Paul Marienfeld GmbH & Co. KG, ChemoMetec A/S, BioTek Instruments, Inc., Becton, Dickinson and Company, Tip Biosystems, Corning Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., GE Healthcare, and Thermo Fisher Scientific
About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
